Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Future Oncology (London, England)|July 19, 2018
The next generation of therapy for multiple myeloma: a review of ongoing clinical trials utilizing ClinicalTrials.govPeter Barth, Colin Vale, Alison B Chambers, et al.
Leukemia Research|December 1, 2017
Extracellular vesicles in leukemiaAlejandro Pando, John L Reagan, Peter Quesenberry, et al.
Transfusion|September 28, 2018
Refractoriness to red blood cell transfusion therapy due to hypersplenismIlyas Sahin, John L Reagan, Rabin Niroula, et al.
Gene|October 8, 2022
Tumor Derived Extracellular Vesicles Modulate Gene Expression in T cellsAlejandro Pando, Christoph Schorl, Loren D Fast, et al.
British Journal of Haematology|February 19, 2014
Viral lymphomagenesis: from pathophysiology to the rationale for novel therapiesJorge J Castillo, John L Reagan, Kenneth D Bishop, et al.
Discovery Medicine|January 14, 2014
Advances in cellular therapy for the treatment of leukemiaKalyan Mantripragada, John L Reagan, Peter J Quesenberry, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 22, 2020
Antifungal prophylaxis during 7 + 3 induction chemotherapy for acute myeloid leukemia is associated with improved survival, in a setting with low incidence of invasive mold infectionsAndrew Hsu, Robert Matera, Kendra Vieira, et al.
American Journal of Hematology|December 19, 2019
Outcomes of bendamustine- or cyclophosphamide-based first-line chemotherapy in older patients with indolent B-cell lymphomaAdam J Olszewski, James N Butera, John L Reagan, et al.
British Journal of Haematology|January 24, 2015
Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphomaJorge J Castillo, John L Reagan, William M Sikov, et al.
Pageof 7